JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Limbach Holdings
LMB
$586M
| $3.55M | ﹤0.01% |
41,483
+36,289
| +699% | +$3.2M |
2023 Q1
7 quarters
|
|
3552
OmniAb
OABI
$708M
| $3.55M | ﹤0.01% |
1,001,797
+854,929
| +582% | +$3.38M |
2022 Q4
8 quarters
|
|
|
WBA
3553
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $3.55M | ﹤0.01% |
+380,000
| New | +$3.53M |
2024 Q4
0 quarters
|
|
|
BOW
3554
Bowhead Specialty Holdings
BOW
$1.11B
| $3.55M | ﹤0.01% |
99,813
+50,491
| +102% | +$1.66M |
2024 Q3
1 quarter
|
|
3555
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.1B
| $3.54M | ﹤0.01% |
116,240
-272,453
| -70% | -$8.73M |
2022 Q4
8 quarters
|
|
3556
Marcus Corp
MCS
$834M
| $3.54M | ﹤0.01% |
164,783
+12,638
| +8% | +$251K |
2016 Q1
35 quarters
|
|
3557
CALL
Regions Financial
RF
$23.1B
| $3.54M | ﹤0.01% |
150,600
-149,500
| -50% | -$3.69M |
2024 Q2
2 quarters
|
|
|
JAMF
3558
DELISTED
Jamf
JAMF
| $3.54M | ﹤0.01% |
252,039
+150,635
| +149% | +$2.37M |
2020 Q3
17 quarters
|
|
|
JKS
3559
CALL
JinkoSolar
JKS
$479M
| $3.54M | ﹤0.01% |
+142,100
| New | +$3.47M |
2024 Q4
0 quarters
|
|
3560
Xeris Biopharma Holdings
XERS
$1.66B
| $3.54M | ﹤0.01% |
1,043,441
+651,481
| +166% | +$2.1M |
2018 Q3
25 quarters
|
|
3561
State Street SPDR S&P Metals & Mining ETF
XME
$4.21B
| $3.52M | ﹤0.01% |
62,100
-562,602
| -90% | -$36.2M |
2015 Q4
36 quarters
|
|
|
OKLO
3562
Oklo
OKLO
$6.67B
| $3.52M | ﹤0.01% |
165,909
+135,570
| +447% | +$2.63M |
2023 Q1
7 quarters
|
|
3563
Kodiak Gas Services
KGS
$5.49B
| $3.52M | ﹤0.01% |
86,150
-24,275
| -22% | -$878K |
2023 Q3
5 quarters
|
|
3564
Vanguard Long-Term Bond ETF
BLV
$5.42B
| $3.52M | ﹤0.01% |
51,398
-5,837
| -10% | -$417K |
2021 Q1
15 quarters
|
|
3565
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$273M
| $3.51M | ﹤0.01% |
84,699
+70,810
| +510% | +$2.99M |
2022 Q4
8 quarters
|
|
3566
VanEck Merk Gold Trust
OUNZ
$2.68B
| $3.51M | ﹤0.01% |
+138,636
| New | +$3.56M |
2024 Q4
0 quarters
|
|
3567
F&G Annuities & Life
FG
$2.87B
| $3.5M | ﹤0.01% |
84,528
+38,576
| +84% | +$1.7M |
2022 Q4
8 quarters
|
|
|
WOW
3568
DELISTED
WideOpenWest
WOW
| $3.5M | ﹤0.01% |
706,080
+204,926
| +41% | +$1.05M |
2017 Q4
28 quarters
|
|
|
OSG
3569
Octave Specialty Group
OSG
$207M
| $3.5M | ﹤0.01% |
276,762
+22,690
| +9% | +$274K |
2013 Q2
46 quarters
|
|
3570
Nokia
NOK
$59.3B
| $3.5M | ﹤0.01% |
790,129
+59,818
| +8% | +$267K |
2013 Q2
46 quarters
|
|
3571
PUT
BP
BP
$115B
| $3.5M | ﹤0.01% |
+118,300
| New | +$3.55M |
2024 Q4
0 quarters
|
|
3572
Sotera Health
SHC
$5.2B
| $3.49M | ﹤0.01% |
255,341
+6,194
| +2% | +$89.8K |
2020 Q4
16 quarters
|
|
3573
PUT
Brinker International
EAT
$8.46B
| $3.49M | ﹤0.01% |
26,400
+17,000
| +181% | +$1.91M |
2024 Q3
1 quarter
|
|
3574
Dimensional Global Real Estate ETF
DFGR
$3.63B
| $3.49M | ﹤0.01% |
136,697
+12,745
| +10% | +$350K |
2023 Q1
7 quarters
|
|
3575
CALL
The GEO Group
GEO
$4.13B
| $3.49M | ﹤0.01% |
124,700
-160,200
| -56% | -$3.55M |
2024 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.